Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Beta-Blockers |
Security Level |
 |
Mechanism |
Beta-Blockers: Barbiturates may decrease the serum concentration of Beta-Blockers. Exceptions: Atenolol; Levobunolol; Metipranolol; Nadolol. |
Management |
Monitor therapy |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Beta-Blockers
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Beta-Blockers Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Beta-Blockers
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.